JASIL Trademark

Trademark Overview

On Tuesday, July 3, 2012, a trademark application was filed for JASIL with the United States Patent and Trademark Office. The USPTO has given the JASIL trademark a serial number of 85668040. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 29, 2016. This trademark is owned by Glaxo Group Limited. The JASIL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
jasil

General Information

Serial Number85668040
Word MarkJASIL
Filing DateTuesday, July 3, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 29, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 4, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "JASIL" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 11, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, February 29, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 29, 2016ABANDONMENT - NO USE STATEMENT FILED
Friday, July 10, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 9, 2015EXTENSION 5 GRANTED
Tuesday, June 23, 2015EXTENSION 5 FILED
Tuesday, June 23, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 23, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 22, 2014EXTENSION 4 GRANTED
Friday, December 12, 2014EXTENSION 4 FILED
Friday, December 12, 2014TEAS EXTENSION RECEIVED
Friday, June 27, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 26, 2014EXTENSION 3 GRANTED
Friday, June 13, 2014EXTENSION 3 FILED
Friday, June 13, 2014TEAS EXTENSION RECEIVED
Wednesday, March 5, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 4, 2014EXTENSION 2 GRANTED
Monday, January 27, 2014EXTENSION 2 FILED
Monday, February 24, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 24, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 27, 2014TEAS EXTENSION RECEIVED
Thursday, July 25, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 23, 2013EXTENSION 1 GRANTED
Tuesday, July 23, 2013EXTENSION 1 FILED
Tuesday, July 23, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 29, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 4, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 4, 2012PUBLISHED FOR OPPOSITION
Wednesday, November 14, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 30, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 24, 2012ASSIGNED TO EXAMINER
Wednesday, July 11, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, July 6, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

jasil pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological